Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Journal of Cellular and Molecular Medicine|March 21, 2007
Blocking translocation of cell surface molecules from the ER to the cell surface by intracellular antibodies targeted to the ERThomas BöldickeProtein Science : a Publication of the Protein Society|March 9, 2017
Single domain antibodies for the knockdown of cytosolic and nuclear proteinsThomas BöldickeAntibodies (Basel, Switzerland)|July 27, 2022
Therapeutic Potential of Intrabodies for Cancer Immunotherapy: Current Status and Future DirectionsThomas BöldickeInternational Journal of Molecular Sciences|January 8, 2025
Genetically Engineered T Cells and Recombinant Antibodies to Target Intracellular Neoantigens: Current Status and Future DirectionsAna Maria Waaga-Gasser, Thomas BöldickeAdvances in Experimental Medicine and Biology|May 30, 2016
Recent Advances with ER Targeted IntrabodiesAndrea L J Marschall, Stefan Dübel, Thomas BöldickeMabs|August 8, 2015
Specific in vivo knockdown of protein function by intrabodiesAndrea L J Marschall, Stefan Dübel, Thomas BöldickeMethods (San Diego, Calif.)|November 1, 2011
Functional inhibition of transitory proteins by intrabody-mediated retention in the endoplasmatic reticulumThomas Böldicke, Stefan Somplatzki, Galina Sergeev, et al.BMC Biotechnology|May 14, 2017
Intrabodies against the Polysialyltransferases ST8SiaII and ST8SiaIV inhibit Polysialylation of NCAM in rhabdomyosarcoma tumor cellsStefan Somplatzki, Martina Mühlenhoff, Andrea Kröger, et al.Journal of Immunological Methods|June 11, 2005
Novel highly efficient intrabody mediates complete inhibition of cell surface expression of the human vascular endothelial growth factor receptor-2 (VEGFR-2/KDR)Thomas Böldicke, Holger Weber, Peter P Mueller, et al.Antibodies (Basel, Switzerland)|February 23, 2024
TLR2 and TLR9 Blockade Using Specific Intrabodies Inhibits Inflammation-Mediated Pancreatic Cancer Cell GrowthAmrendra K Ajay, Martin Gasser, Li-Li Hsiao, et al.Pageof 2